Shopping Cart 0
Cart Subtotal
USD 0

DaVita Inc (DVA) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Single User License
USD 250

Restricted to one authorized user; Open on 1 PC/ mobile / Tablet only.
Print Option: No
Copy Option: No
Download Option: No
Deliverable Format : PDF viewable on the website via username

Site License
USD 500

Multiple Users within the Company/ Enterprise
Print Option: Yes
Copy Option: Yes
Download Option: Yes
Deliverable Format : Excel, PDF viewable on the website via username

Corporate User License
USD 750

Details

Summary

DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). It also provides integrated health care delivery and management services. DaVita offers ancillary services, including pharmacy services such as DaVita Rx; infusion therapy services, disease management services; vascular access services; ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. DaVita Medical Group manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, Florida, New Mexico and Colorado. DaVita is headquartered in Denver, Colorado, the US.

DaVita Inc (DVA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Table Of Content

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

DaVita Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

DaVita Inc, Medical Devices Deals, 2012 to YTD 2018 10

DaVita Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

DaVita Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

DSI Renal Acquires Corva Kidney Center Webster from Corva 12

DaVita Healthcare to Acquire Dialysis Units from Arnot Medical for USD7 Million 13

DSI Renal Acquires New Smyrna Beach Artificial Kidney Center In Florida From Kru Medical Ventures 14

Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 15

DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 16

Venture Financing 17

Nephrolife Care Raises USD 25 Million In Series A Financing 17

Partnerships 18

Quintiles Enters into Agreement with DaVita Clinical Research 18

DaVita to Form Joint Venture with Xiaoyi Zhang 19

Genesis Health System Forms Joint Venture with DaVita HealthCare 20

Independence Blue Cross Forms Joint Venture With DaVita HealthCare Partners 21

DaVita Enters Into Joint Venture Agreement With Riches Healthcare 22

3SBio Enters Into Joint Venture Agreement With DaVita For Dialysis Treatment 23

Merger 24

DSI Renal And U.S. Renal Care to Merge 24

Debt Offering 25

DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 25

DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 27

DaVita Completes Public Offering Of Senior Notes Due 2022 For USD 1.25 Billion 29

Acquisition 31

DaVita HealthCare Acquires Remaining Stake in Nephrolife Care 31

DaVita Healthcare Acquires Majority Stake in Express Clinics 32

DaVita HealthCare Partners Acquires Majority Stake In Esensa, Renal Services Provider 33

BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For USD 70 Million 34

DaVita Completes Acquisition Of HealthCare Partners, Doctor Network Operator, For Up To USD 4.7 Billion 35

DaVita Acquires Lehbi Care, Kidney Care Company 37

DaVita Inc-Key Competitors 38

DaVita Inc-Key Employees 39

DaVita Inc-Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Joint Venture 43

Recent Developments 44

Strategy And Business Planning 44

Sep 11, 2018: DaVita labs opens 150,000 square-foot campus in DeLand 44

Jun 06, 2017: DaVita Introduces DaVita Health Solutions 45

Financial Announcements 46

Aug 01, 2018: DaVita 2nd quarter 2018 results 46

May 03, 2018: DaVita 1st Quarter 2018 Results 48

Feb 13, 2018: DaVita 4th Quarter 2017 Results 50

Nov 07, 2017: DaVita 3rd Quarter 2017 Results 52

Aug 01, 2017: DaVita Reports 2nd Quarter 2017 Results 54

May 02, 2017: DaVita Reports 1st Quarter 2017 Results 56

Feb 16, 2017: DaVita 4th Quarter 2016 Results 58

Corporate Communications 60

Aug 28, 2018: DaVita names Partha Das as new Chief Medical Officer for International Operations 60

May 01, 2018: DaVita Kidney Care Appoints Dr. David Roer To Physician Leadership Team 61

May 24, 2017: DaVita Kidney Care Welcomes Eric Severson as Chief People Officer 62

May 18, 2017: Dr. George R. Aronoff Joins DaVita Kidney Care Physician Leadership Team 63

Apr 10, 2017: DaVita Names New President of International 64

Feb 28, 2017: Dr. Adam Weinstein Joins DaVita Kidney Care Physician Leadership Team 65

Feb 23, 2017: DaVita Appoints Chief Medical Officer for Integrated Kidney Care 66

Jan 05, 2017: DaVita Announces Joel Ackerman to be CFO 67

Jan 05, 2017: DaVita Appoints Pascal Desroches to Board of Directors 68

Legal and Regulatory 69

Oct 08, 2018: Davita's Inpatient Hospital services program reaccredited by the Joint Commission 69

Oct 01, 2018: Medicare advantage provider to pay USD 270 Million to settle false claims act liabilities 70

Jul 03, 2018: Paynter Law Firm Announces USD 383.5 Million Jury Verdict. 72

Jun 29, 2018: Families of Two California Patients Awarded USD 253 Million in Wrongful Death Lawsuits Against Dialysis Corporation DaVita, Reports Kidney Patients Deserve Better 73

Dec 14, 2017: DaVita Kidney Care Issues Statement about DaVita Rx Settlement 74

Jan 06, 2017: Dialysis Community Seeks Emergency Relief to Block CMS' Unlawful "Midnight" Rule Harming Patients 75

Government and Public Interest 76

Jun 30, 2018: DaVita Responds to Senate Bill 1156 Veto 76

Nov 03, 2017: DaVita Joins Patients in Urging Congress to Pass the Bipartisan Dialysis PATIENTS Demonstration Act 77

Jan 25, 2017: DaVita Responds to US District Court, Eastern District of Texas Ruling Protecting Dialysis Patients from Discrimination by Insurance Companies 78

Other Significant Developments 79

Apr 24, 2018: DaVita and Methodist Specialty and Transplant Hospital Collaborate to Launch Technology Designed to Help Improve Transplant Readiness of Patients 79

Jan 03, 2018: DaVita Celebrates 2017 Innovations and Achievements 80

Dec 14, 2017: DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions 84

Oct 31, 2017: The Everett Clinic Plays a Leading Role in Addressing Opioid Epidemic 85

May 12, 2017: DaVita Helps Raise Awareness of Mental Illness During Mental Health Month 86

Appendix 87

Methodology 87

About GlobalData 87

Contact Us 87

Disclaimer 87


List Of Figure

List of Figures

DaVita Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

DaVita Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

DaVita Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

DaVita Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

DaVita Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

DaVita Inc, Deals By Therapy Area, 2012 to YTD 2018 9

DaVita Inc, Medical Devices Deals, 2012 to YTD 2018 10

DaVita Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

DSI Renal Acquires Corva Kidney Center Webster from Corva 12

DaVita Healthcare to Acquire Dialysis Units from Arnot Medical for USD7 Million 13

DSI Renal Acquires New Smyrna Beach Artificial Kidney Center In Florida From Kru Medical Ventures 14

Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 15

DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 16

Nephrolife Care Raises USD 25 Million In Series A Financing 17

Quintiles Enters into Agreement with DaVita Clinical Research 18

DaVita to Form Joint Venture with Xiaoyi Zhang 19

Genesis Health System Forms Joint Venture with DaVita HealthCare 20

Independence Blue Cross Forms Joint Venture With DaVita HealthCare Partners 21

DaVita Enters Into Joint Venture Agreement With Riches Healthcare 22

3SBio Enters Into Joint Venture Agreement With DaVita For Dialysis Treatment 23

DSI Renal And U.S. Renal Care to Merge 24

DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 25

DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 27

DaVita Completes Public Offering Of Senior Notes Due 2022 For USD 1.25 Billion 29

DaVita HealthCare Acquires Remaining Stake in Nephrolife Care 31

DaVita Healthcare Acquires Majority Stake in Express Clinics 32

DaVita HealthCare Partners Acquires Majority Stake In Esensa, Renal Services Provider 33

BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For USD 70 Million 34

DaVita Completes Acquisition Of HealthCare Partners, Doctor Network Operator, For Up To USD 4.7 Billion 35

DaVita Acquires Lehbi Care, Kidney Care Company 37

DaVita Inc, Key Competitors 38

DaVita Inc, Key Employees 39

DaVita Inc, Other Locations 40

DaVita Inc, Subsidiaries 41

DaVita Inc, Joint Venture 43

Licence Rights

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

Section Purchase

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products and Companies

Products

DaVita Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.

Company Profile

Company Profile Title

Summary

DaVita Inc (DaVita), formerly DaVita HealthCare Partners Inc., is a provider of dialysis services and integrated health care delivery and management services. The company is a provider of dialysis services in the US for patients with chronic kidney failure and end-stage renal disease (ESRD). It also provides integrated health care delivery and management services. DaVita offers ancillary services, including pharmacy services such as DaVita Rx; infusion therapy services, disease management services; vascular access services; ESRD clinical research programs and physician services. The company operates through a network of outpatient dialysis centers in hospitals and related laboratory services. DaVita Medical Group manages and operates medical groups and affiliated physician networks in Arizona, California, Nevada, Florida, New Mexico and Colorado. DaVita is headquartered in Denver, Colorado, the US.

DaVita Inc (DVA)-Pharmaceuticals & Healthcare-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.

- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.

- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.

- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.

- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.

- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.

- Business Description-A brief description of the company's operations.

- Key Employees-A list of the key executives of the company.

- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.

- Key Competitors-A list of the key competitors of the company.

- Key Recent Developments-A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements

- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy

- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company

- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.

- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company

- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research

- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

READ MORE

Scope

Table of Contents

Table of Contents 3

List of Tables 5

List of Figures 5

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

DaVita Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

DaVita Inc, Medical Devices Deals, 2012 to YTD 2018 10

DaVita Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

DaVita Inc, Pharmaceuticals & Healthcare, Deal Details 12

Asset Purchase 12

DSI Renal Acquires Corva Kidney Center Webster from Corva 12

DaVita Healthcare to Acquire Dialysis Units from Arnot Medical for USD7 Million 13

DSI Renal Acquires New Smyrna Beach Artificial Kidney Center In Florida From Kru Medical Ventures 14

Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 15

DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 16

Venture Financing 17

Nephrolife Care Raises USD 25 Million In Series A Financing 17

Partnerships 18

Quintiles Enters into Agreement with DaVita Clinical Research 18

DaVita to Form Joint Venture with Xiaoyi Zhang 19

Genesis Health System Forms Joint Venture with DaVita HealthCare 20

Independence Blue Cross Forms Joint Venture With DaVita HealthCare Partners 21

DaVita Enters Into Joint Venture Agreement With Riches Healthcare 22

3SBio Enters Into Joint Venture Agreement With DaVita For Dialysis Treatment 23

Merger 24

DSI Renal And U.S. Renal Care to Merge 24

Debt Offering 25

DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 25

DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 27

DaVita Completes Public Offering Of Senior Notes Due 2022 For USD 1.25 Billion 29

Acquisition 31

DaVita HealthCare Acquires Remaining Stake in Nephrolife Care 31

DaVita Healthcare Acquires Majority Stake in Express Clinics 32

DaVita HealthCare Partners Acquires Majority Stake In Esensa, Renal Services Provider 33

BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For USD 70 Million 34

DaVita Completes Acquisition Of HealthCare Partners, Doctor Network Operator, For Up To USD 4.7 Billion 35

DaVita Acquires Lehbi Care, Kidney Care Company 37

DaVita Inc-Key Competitors 38

DaVita Inc-Key Employees 39

DaVita Inc-Locations And Subsidiaries 40

Head Office 40

Other Locations & Subsidiaries 40

Joint Venture 43

Recent Developments 44

Strategy And Business Planning 44

Sep 11, 2018: DaVita labs opens 150,000 square-foot campus in DeLand 44

Jun 06, 2017: DaVita Introduces DaVita Health Solutions 45

Financial Announcements 46

Aug 01, 2018: DaVita 2nd quarter 2018 results 46

May 03, 2018: DaVita 1st Quarter 2018 Results 48

Feb 13, 2018: DaVita 4th Quarter 2017 Results 50

Nov 07, 2017: DaVita 3rd Quarter 2017 Results 52

Aug 01, 2017: DaVita Reports 2nd Quarter 2017 Results 54

May 02, 2017: DaVita Reports 1st Quarter 2017 Results 56

Feb 16, 2017: DaVita 4th Quarter 2016 Results 58

Corporate Communications 60

Aug 28, 2018: DaVita names Partha Das as new Chief Medical Officer for International Operations 60

May 01, 2018: DaVita Kidney Care Appoints Dr. David Roer To Physician Leadership Team 61

May 24, 2017: DaVita Kidney Care Welcomes Eric Severson as Chief People Officer 62

May 18, 2017: Dr. George R. Aronoff Joins DaVita Kidney Care Physician Leadership Team 63

Apr 10, 2017: DaVita Names New President of International 64

Feb 28, 2017: Dr. Adam Weinstein Joins DaVita Kidney Care Physician Leadership Team 65

Feb 23, 2017: DaVita Appoints Chief Medical Officer for Integrated Kidney Care 66

Jan 05, 2017: DaVita Announces Joel Ackerman to be CFO 67

Jan 05, 2017: DaVita Appoints Pascal Desroches to Board of Directors 68

Legal and Regulatory 69

Oct 08, 2018: Davita's Inpatient Hospital services program reaccredited by the Joint Commission 69

Oct 01, 2018: Medicare advantage provider to pay USD 270 Million to settle false claims act liabilities 70

Jul 03, 2018: Paynter Law Firm Announces USD 383.5 Million Jury Verdict. 72

Jun 29, 2018: Families of Two California Patients Awarded USD 253 Million in Wrongful Death Lawsuits Against Dialysis Corporation DaVita, Reports Kidney Patients Deserve Better 73

Dec 14, 2017: DaVita Kidney Care Issues Statement about DaVita Rx Settlement 74

Jan 06, 2017: Dialysis Community Seeks Emergency Relief to Block CMS' Unlawful "Midnight" Rule Harming Patients 75

Government and Public Interest 76

Jun 30, 2018: DaVita Responds to Senate Bill 1156 Veto 76

Nov 03, 2017: DaVita Joins Patients in Urging Congress to Pass the Bipartisan Dialysis PATIENTS Demonstration Act 77

Jan 25, 2017: DaVita Responds to US District Court, Eastern District of Texas Ruling Protecting Dialysis Patients from Discrimination by Insurance Companies 78

Other Significant Developments 79

Apr 24, 2018: DaVita and Methodist Specialty and Transplant Hospital Collaborate to Launch Technology Designed to Help Improve Transplant Readiness of Patients 79

Jan 03, 2018: DaVita Celebrates 2017 Innovations and Achievements 80

Dec 14, 2017: DaVita Addresses Physician Fatigue with Investment in DaVita Physician Solutions 84

Oct 31, 2017: The Everett Clinic Plays a Leading Role in Addressing Opioid Epidemic 85

May 12, 2017: DaVita Helps Raise Awareness of Mental Illness During Mental Health Month 86

Appendix 87

Methodology 87

About GlobalData 87

Contact Us 87

Disclaimer 87


List Of Figure

List of Figures

DaVita Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

DaVita Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9

DaVita Inc, Medical Devices Deals, 2012 to YTD 2018 10


List Of Table

List of Tables

DaVita Inc, Pharmaceuticals & Healthcare, Key Facts, 2017 2

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6

DaVita Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7

DaVita Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8

DaVita Inc, Deals By Therapy Area, 2012 to YTD 2018 9

DaVita Inc, Medical Devices Deals, 2012 to YTD 2018 10

DaVita Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11

DSI Renal Acquires Corva Kidney Center Webster from Corva 12

DaVita Healthcare to Acquire Dialysis Units from Arnot Medical for USD7 Million 13

DSI Renal Acquires New Smyrna Beach Artificial Kidney Center In Florida From Kru Medical Ventures 14

Davita Acquires Nine Dialysis Centers From Fresenius Medical Care 15

DSI Renal Acquires 54 Dialysis Clinics From Fresenius Medical Care North America 16

Nephrolife Care Raises USD 25 Million In Series A Financing 17

Quintiles Enters into Agreement with DaVita Clinical Research 18

DaVita to Form Joint Venture with Xiaoyi Zhang 19

Genesis Health System Forms Joint Venture with DaVita HealthCare 20

Independence Blue Cross Forms Joint Venture With DaVita HealthCare Partners 21

DaVita Enters Into Joint Venture Agreement With Riches Healthcare 22

3SBio Enters Into Joint Venture Agreement With DaVita For Dialysis Treatment 23

DSI Renal And U.S. Renal Care to Merge 24

DaVita HealthCare Prices Public Offering of 5% Notes Due 2025 for USD1.5 Billion 25

DaVita HealthCare Raises USD1.75 Billion in Public Offering of 5.125% Notes Due 2024 27

DaVita Completes Public Offering Of Senior Notes Due 2022 For USD 1.25 Billion 29

DaVita HealthCare Acquires Remaining Stake in Nephrolife Care 31

DaVita Healthcare Acquires Majority Stake in Express Clinics 32

DaVita HealthCare Partners Acquires Majority Stake In Esensa, Renal Services Provider 33

BioScrip Completes Acquisition Of HomeChoice Partners, Infusion Services Company, For USD 70 Million 34

DaVita Completes Acquisition Of HealthCare Partners, Doctor Network Operator, For Up To USD 4.7 Billion 35

DaVita Acquires Lehbi Care, Kidney Care Company 37

DaVita Inc, Key Competitors 38

DaVita Inc, Key Employees 39

DaVita Inc, Other Locations 40

DaVita Inc, Subsidiaries 41

DaVita Inc, Joint Venture 43

Single User License:
Report can be used by individual purchaser only

Site License:
Report can be shared by unlimited users within one corporate location, e.g. a regional office

Corporate User License: 
Report can be shared globally by unlimited users within the purchasing corporation e.g. all employees of a single company

To know more information on Purchase by Section, please send a mail to support@kenresearch.com

INQUIRE FOR COVID-19 IMPACT ANALYSIS

Products

DaVita Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.